Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
Syringocystadenocarcinoma papilliferum (SCACP) is a rare adenexal carcinoma with only 21 cases reported in the literature. Most patients describe a long-standing mass with recent change, supporting the idea that SCACP arises from malignant transformation of pre-existing syringocystadenoma papilliferum (SCAP). Syringocystadenocarcinoma papilliferum is generally treated with wide surgical excision of the lesion and patients do exceeding well and require no systemic therapy.
University of Kansas Medical Center.
Johanna
J
Peterson
Kimberly
K
Tefft
Joseph
J
Blackmon
Anand
A
Rajpara
Garth
G
Fraga
D006607:Adenoma, Sweat Gland / Q000151:congenital / Q000473:pathology; D000368:Aged; D003536:Cystadenocarcinoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D018450:Disease Progression; D006258:Head and Neck Neoplasms / Q000151:congenital / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D006801:Humans; D008297:Male; D012535:Scalp / Q000473:pathology*; D013544:Sweat Gland Neoplasms / Q000151:congenital / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery